Figure 1. Clinical outcomes according to MALT-IPI risk groups in the testing set. Kaplan-Meier estimates for EFS (A), PFS (B), CSS (C), and OS (D) in the testing set from the IELSG-19 clinical trial database.
Figure 1.

Clinical outcomes according to MALT-IPI risk groups in the testing set. Kaplan-Meier estimates for EFS (A), PFS (B), CSS (C), and OS (D) in the testing set from the IELSG-19 clinical trial database.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal